LINC02102

Across TCGA pan-cancer cohorts, LINC02102 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02102 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02102 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02102 expression acts as an unfavorable survival marker, although some lineages such as PAAD and HNSC show a favorable association.

ACC, PAAD, and KIRP are the cancer types where LINC02102 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	III,IV	0.269	0.965	.006	64	view →
PAAD	DFS	Median	All	0.496	0.259	.002	49	view →
KIRP	DFS	Tertile	All	0.760	0.927	.002	38	view →
KIRC	DFS	Median	All	0.515	0.686	.002	37	view →
COAD	OS	Tertile	All	0.747	0.894	.007	29	view →
PRAD	DFS	Median	All	0.832	0.934	<.001	24	view →
HNSC	DFS	Tertile	All	0.764	0.648	.005	23	view →
LGG	DFS	Tertile	All	0.776	0.887	<.001	19	view →
READ	DFS	Median	All	0.245	0.646	.008	15	view →
SKCM	DFS	Median	All	0.772	0.685	.017	15	view →
UCS	DFS	Tertile	IV	0.855	0.381	.024	12	view →
LAML	DFS	Tertile	All	0.269	0.548	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02102–ACC (DFS)

Open the ACC breakdown →